Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28821415 | 0.87 | TSHR (0.38) | LMNAALOX15HSD17B10TSHRALDH1A1 | |
| Acrylic Acid SCHEMBL27663274 | 0.81 | — | — | |
| SCHEMBL152575 | 0.81 | — | — | |
| SCHEMBL27373943 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL28167553 | 0.78 | — | — | |
| Ammonia Solution, Strong SCHEMBL26607429 | 0.78 | — | — | |
| Acrylic Acid SCHEMBL614673 | 0.78 | — | — | |
| Acrylic Acid SCHEMBL7917031 | 0.78 | — | — | |
| Acrylic Acid SCHEMBL38660266 | 0.76 | — | — | |
| Acrylic Acid SCHEMBL9073272 | 0.76 | LMNA (0.59) | LMNAALOX15HSD17B10TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050075511-A1 | Phosphorous organic compounds and their use | JOMAA HASSAN (DE) | 2005-04-07 | — | — | US | disclosed |
| US-6812224-B2 | A FUNGICIDE, BACTERICIDE TREATING INFECTIONS IN HUMANS, ANIMALS, PLANTS AND HERBICIDE IN PLANTS | JOMAA PHARMAKA GMBH (DE) | 2004-11-02 | — | — | US | disclosed |
| US-20030045746-A1 | Phosphorous organic compounds and their use | JOMAA PHARMAKA GMBH (DE) | 2003-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030045746-A1 | Phosphorous organic compounds and their use | PPM1D, PFAS, PPM1F | LMNA 3842/4885ALOX15 2162/4885HSD17B10 2171/4885 |
| US-20050075511-A1 | Phosphorous organic compounds and their use | PFAS, PNPO, PPM1B | LMNA 4226/4885ALOX15 2269/4885HSD17B10 1695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.